FOXP3 and neoplasm: In conclusion, to target Tregs in the pancreatic microenvironment, a deeper phenotyping of Treg subpopulations, including the quantification of Foxp3 expression levels throughout tumor progression is needed for the optimization of therapeutic strategies aiming to deplete or disable intratumoral Tregs [11].